drug
as of 2026-07-01GlyT-1 inhibitor-1
at a glance
small molecule
Pre-approval / investigational in the US
Developed by China Medical University Hospital
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
GlyT-1 Inhibitor Treatment for Refractory Schizophrenia
NCT01251055Phase 2Completed
KOLs & investigators
1
Hsien-Yuan Lane, MD.PhD.KOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here